1887

oa SA Pharmaceutical Journal - Oral hypoglycaemic drugs and newer agents use in type 2 diabetes mellitus : clinical

Volume 75, Issue 9
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017

 

Abstract

We have reviewed the use of oral agents in the management of type 2 diabetes, together with their pharmacological mechanisms, indications, side effects and contra-indications. The principal oral agents available for use include metformin, sulphonylureas, non-sulphonylurea secretagogues (), thiazolidinediones, and -glucosidase inhibitors. More recently, DPP-IV inhibitors and glucagon-like peptide-1 agents have been registered for use in the United States and in Europe. They await Medicines Control Council registration for use in South Africa.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/mp_sapj/75/9/EJC82052
2008-10-01
2017-10-22

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error